Literature DB >> 27860285

1H-1,2,3-triazole-tethered uracil-ferrocene and uracil-ferrocenylchalcone conjugates: Synthesis and antitubercular evaluation.

Amandeep Singh1, Christophe Biot2,3, Albertus Viljoen4, Christian Dupont4, Laurent Kremer4,5, Kewal Kumar1,6, Vipan Kumar1.   

Abstract

Copper-catalyzed azide-alkyne [3 + 2] cycloaddition has been utilized for preparing a series of 1H-1,2,3-triazoles with the purpose of probing structure-activity relationships among a uracil-ferrocene-triazole conjugate family. The antitubercular evaluation studies revealed an improvement in activity with the introduction of a ferrocene nucleus among N-alkylazido-uracil precursors, with a preference for a bromo-substituent along with moderate chain lengths of n = 2-6. The reported protocol is a successful approach for integrating uracil-ferrocene-chalcone functionalities tethered via 1H-1,2,3-triazole rings with apparent physicochemical stability.
© 2016 John Wiley & Sons A/S.

Entities:  

Keywords:  antitubercular activity; azide-alkyne cycloaddition reaction; structure-activity relationship; uracil-ferrocenylchalcones conjugates

Mesh:

Substances:

Year:  2016        PMID: 27860285     DOI: 10.1111/cbdd.12908

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  3 in total

Review 1.  An Updated Review on the Synthesis and Antibacterial Activity of Molecular Hybrids and Conjugates Bearing Imidazole Moiety.

Authors:  Renzo Rossi; Maurizio Ciofalo
Journal:  Molecules       Date:  2020-11-04       Impact factor: 4.411

2.  Synthesis, anti-mycobacterial and cytotoxic evaluation of substituted isoindoline-1,3-dione-4-aminoquinolines coupled via alkyl/amide linkers.

Authors:  Anu Rani; Albertus Viljoen; Matt D Johansen; Laurent Kremer; Vipan Kumar
Journal:  RSC Adv       Date:  2019-03-13       Impact factor: 4.036

3.  Palladium-catalyzed C-H olefination of uridine, deoxyuridine, uridine monophosphate and uridine analogues.

Authors:  Qin Zhao; Ruoqian Xie; Yuxiao Zeng; Wanlu Li; Guolan Xiao; Yangyan Li; Gang Chen
Journal:  RSC Adv       Date:  2022-09-01       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.